As the expression of DPP4 increased in the adipose tissue of obese patients (22, 23) and some specific cancer patients (Figure 2, Table 1), it was anticipated to reduce the infection rate of SARS-CoV-2 in patients by treatment with DPP4 inhibitors, while further clinical trials are needed to verify our hypothesis. Here, DPP4 is linked to cancer.